Plandai Biotech Stock Price on September 12, 2024
| PLPL Stock | USD 0.0002 0.0001 100.00% |
If you're considering investing in Plandai Pink Sheet, it is important to understand the factors that can impact its price. As of today, the current price of Plandai Biotech stands at 0.0002, as last reported on the 28th of November, with the highest price reaching 0.0002 and the lowest price hitting 0.0001 during the day. Plandai Biotech is out of control given 3 months investment horizon. Plandai Biotech maintains Sharpe Ratio (i.e., Efficiency) of 0.2, which implies the firm had a 0.2% return per unit of risk over the last 3 months. We were able to interpolate data for twenty-nine different technical indicators, which can help you to evaluate if expected returns of 9.64% are justified by taking the suggested risk. Use Plandai Biotech Risk Adjusted Performance of 0.16, semi deviation of 24.26, and Coefficient Of Variation of 510.44 to evaluate company specific risk that cannot be diversified away.
Plandai Pink Sheet price history is provided at the adjusted basis, taking into account all of the recent filings.
Plandai |
Sharpe Ratio = 0.199
| Best Portfolio | Best Equity | PLPL | ||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 48.41 actual daily | 96 96% of assets are less volatile |
Expected Return
| 5.01 actual daily | 96 96% of assets have lower returns |
Risk-Adjusted Return
| 0.2 actual daily | 15 85% of assets perform better |
Based on monthly moving average Plandai Biotech is performing at about 15% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Plandai Biotech by adding it to a well-diversified portfolio.
Related Headline
Nasdaq Headline on 12th of September 2024
Filed transaction by Nasdaq Inc Officer: Executive Vice President. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Plandai Biotech Valuation on September 12, 2024
It is possible to determine the worth of Plandai Biotech on a given historical date. On September 12, 2024 Plandai was worth 2.0E-4 at the beginning of the trading date compared to the closed value of 2.0E-4. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Plandai Biotech pink sheet. Still, in general, we apply an absolute valuation method to find Plandai Biotech's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Plandai Biotech where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Plandai Biotech's related companies.
| Open | High | Low | Close | Volume | |
| 0.0001 | 0.0002 | 0.0001 | 0.0002 | 7,181,249 | |
09/12/2024 | 0.0002 | 0.0002 | 0.0002 | 0.0002 | 4,828,799 |
| 0.0001 | 0.0002 | 0.0001 | 0.0001 | 4,086,857 |
| Backtest Plandai Biotech | | | Plandai Biotech History | | | Plandai Biotech Valuation | Previous | Next |
Plandai Biotech Trading Date Momentum on September 12, 2024
| On September 13 2024 Plandai Biotech was traded for 0.0001 at the closing time. The top price for the day was 0.0002 and the lowest listed price was 0.0001 . The trading volume for the day was 4.1 M. The trading history from September 13, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 50.00% . The trading delta at closing time against the current closing price is 50.00% . |
Plandai Biotech Fundamentals Correlations and Trends
By evaluating Plandai Biotech's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Plandai Biotech's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Plandai financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Plandai Biotech Pink Sheet history
Plandai Biotech investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Plandai is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Plandai Biotech will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Plandai Biotech stock prices may prove useful in developing a viable investing in Plandai Biotech
Planda Biotechnology, Inc. focuses on the production of proprietary botanical extracts for the nutriceutical and pharmaceutical industries. Planda Biotechnology, Inc. is based in London, the United Kingdom. Diamond Ranch is traded on OTC Exchange in the United States.
Plandai Biotech Pink Sheet Technical Analysis
Plandai Biotech technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
Price Boundaries
Plandai Biotech Period Price Range
Low | November 28, 2024
| High |
0.00 | 0.00 |
Plandai Biotech cannot be verified against its exchange. Please verify the symbol is currently traded on PINK Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Plandai Biotech November 28, 2024 Market Strength
Market strength indicators help investors to evaluate how Plandai Biotech pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Plandai Biotech shares will generate the highest return on investment. By undertsting and applying Plandai Biotech pink sheet market strength indicators, traders can identify Plandai Biotech entry and exit signals to maximize returns
Plandai Biotech Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Plandai Biotech's price direction in advance. Along with the technical and fundamental analysis of Plandai Pink Sheet historical price patterns, it is also worthwhile for investors to track various predictive indicators of Plandai to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.16 | |||
| Jensen Alpha | 10.12 | |||
| Total Risk Alpha | 2.15 | |||
| Sortino Ratio | 0.181 | |||
| Treynor Ratio | (1.37) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Other Information on Investing in Plandai Pink Sheet
Plandai Biotech financial ratios help investors to determine whether Plandai Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Plandai with respect to the benefits of owning Plandai Biotech security.